Posts Tagged ‘aging’


    Loading...

  • GlaxoSmithKline Tells Execs to Leave Nonprofit Selling Resveratrol Supplements

    Saturday, August 14th, 2010 at 02:44 | Comments Off

    Two GSK execs were asked to quit the nonprofit’s board after the drug maker learned it was selling resveratrol supplements.

    See the rest here: GlaxoSmithKline Tells Execs to Leave Nonprofit Selling Resveratrol Supplements

  • Aetna CEO: CVS Partnership Good for Shareholders

    Thursday, July 29th, 2010 at 09:26 | Comments Off

    Aetna Chairman and CEO Ronald Williams discusses the recent partnership between Aetna and CVS Caremark in an interview with WSJ Deputy Managing Editor Alan Murray.

    See more here:  Aetna CEO: CVS Partnership Good for Shareholders/a>

  • What Does Aging Mean for Elite Athletes? (Lance, We Mean You)

    Saturday, July 24th, 2010 at 07:26 | Comments Off

    What’s responsible for the age-related performance declines seen in most sports?

    See more here: What Does Aging Mean for Elite Athletes? (Lance, We Mean You)

  • Study: Avid’s Imaging Dye Can Detect Alzheimer’s From Scan

    Tuesday, July 13th, 2010 at 03:23 | Comments Off

    Bayer and GE are also developing diagnostic compounds to be used in tandem with imaging.

    Here is the original:  Study: Avid’s Imaging Dye Can Detect Alzheimer’s From Scan

  • Does Human Growth Hormone Actually Do Anything for Athletes?

    Thursday, May 20th, 2010 at 00:14 | Comments Off

    Until this month, there wasn’t much solid evidence that HGH improves aspects of athletic performance.

    Read more:  Does Human Growth Hormone Actually Do Anything for Athletes?

  • News Hub: The Sun and Your Health

    Tuesday, April 27th, 2010 at 06:56 | Comments Off

    Skin types at the fair end of the spectrum are more susceptible to the burning rays of the sun — and to a higher risk for cancers and premature aging of the skin. But a little sun exposure also releases endorphins and gives us needed vitamin D. WSJ’s Melinda Beck and Laura Landro debate how good or bad the sun is for you on the News Hub.

    Read the original post:  News Hub: The Sun and Your Health/a>

  • FDA Roundup: Menthol Cigarettes, CT Scans, No Go on Jet-Lag Drug

    Wednesday, March 31st, 2010 at 03:07 | Comments Off

    A few items of interest involving the FDA:

    Congress last year added the tobacco industry to the FDA’s regulatory mix and today a panel of health experts making up the agency’s new Tobacco Products Scientific Advisory Committee is kicking off a two-day meeting. First on the agenda: how menthol flavoring in cigarettes affects smokers’ habits.

    Small wonder that menthol is getting early attention, says the New York Times, which notes menthol butts account for almost a third of the $70 billion U.S. ..read more

  • Content Spurs Changes In U.S. Fitness Sector

    Wednesday, March 17th, 2010 at 04:39 | Comments Off

    Consumer demand for innovation and customization, a boon for new entrants such as Beachbody and CrossFit, could spur capital markets activity in the sector, says Joe Pellegrini, managing director of Robert W. Baird’s consumer investment banking group.

    Read more from the original source: Content Spurs Changes In U.S. Fitness Sector/a>

  • Cutting the Risk from CT Scans

    Tuesday, March 2nd, 2010 at 12:21 | Comments Off

    A nationwide push is underway to lower radiation exposure from CT scans, amid growing concern about the risks of cancer linked to the high-powered imaging technology, as I write in the Informed Patient column today.

    While much of the focus is on adult CT scanning, between 5% and 10% of the approximately 70 million CT scans performed each year are administered to children, who are at higher risk because of their smaller size and the longer life expectancy. The Society for ..read more

  • Pfizer Experimental Bone Drug Shows Mixed Results In Study

    Friday, February 26th, 2010 at 03:28 | Comments Off

    Last we heard of Fablyn, an experimental bone drug for the treatment of postmenopausal women, U.S. regulators were holding off on approval after FDA staff and outside reviewers raised concerns and Pfizer, the pill’s maker, was shopping it around to other companies.

    Today’s New England Journal of Medicine reports that the drug met the goals of a key study. Fablyn prevented certain fractures in postmenopausal women and reduced the risk of breast cancer, said the study, sponsored by Pfizer. However, the ..read more